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Background and methods: Despite continuous efforts, the increasing prevalence of resis-
tance among pathogenic bacteria to common antibiotics has become one of the most significant 
concerns in modern medicine. Nanostructured materials are used in many fields, including 
biological sciences and medicine. While some bismuth derivatives has been used in medicine 
to treat vomiting, nausea, diarrhea, and stomach pain, the biocidal activity of zerovalent   bismuth 
nanoparticles has not yet been studied. The objective of this investigation was to analyze the 
antimicrobial activity of bismuth nanoparticles against oral bacteria and their antibiofilm 
capabilities.
Results: Our results showed that stable colloidal bismuth nanoparticles had 69% antimicrobial 
activity against Streptococcus mutans growth and achieved complete inhibition of biofilm 
formation. These results are similar to those obtained with chlorhexidine, the most commonly 
used oral antiseptic agent. The minimal inhibitory concentration of bismuth nanoparticles that 
interfered with S. mutans growth was 0.5 mM.
Conclusion: These results suggest that zerovalent bismuth nanoparticles could be an interesting 
antimicrobial agent to be incorporated into an oral antiseptic preparation.
Keywords: zerovalent bismuth nanoparticles, antimicrobial agent, biofilm, Streptococcus 
mutans
Introduction
Bacteria in nature do not grow in nutrient-rich medium nor in individual form. 
These microorganisms live in association within communities containing other 
  microorganisms in a cooperative form, known as biofilm. Biofilms can form on all 
kinds of surfaces and interfaces, including the human body.1 The most common 
biofilm is dental plaque in the oral cavity, with Streptococcus mutans being the main 
  etiological agent of dental caries worldwide.2,3 S. mutans has also been identified in 
cases of endocarditis, where it colonizes the endocardium and cardiac valves, probably 
due to an ability to adhere to solid surfaces and form a biofilm.4
Despite continuous efforts on the part of the pharmaceutical industry, increasing 
resistance of microorganisms to common antibiotics has become an important issue 
in current medicine.5 The absence of new alternatives to treat multidrug-resistant 
  pathogenic bacteria efficiently is a real problem, and there is an urgent need to 
  synthesize new broad-spectrum drugs to fight antimicrobial resistance.
Bismuth is a metallic element of the VA group, together with nitrogen, phosphorus, 
antimony, and arsenic. Its oxidation numbers are +3 and +5. It is found in the same 
  proportions as silver in the Earth’s crust, and it occupies the 73rd place in abundance. 
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Typically, it is found as bismuthinite (bismuth sulfide), bismite 
(bismuth oxide), and bismuthite (bismuth carbonate).6 Mexico is 
the second most important producer of bismuth worldwide after 
China. Bismuth is used in the manufacture of pharmaceutical 
products, cosmetics, catalysts, pigments, electronics, and alloys. 
In medicine, bismuth subsalicylate has been used as an antidiar-
rheal agent to treat nausea, vomiting, and stomach pain.7
Recently, zerovalent bismuth nanoparticles have attracted 
interest because of their potential application in electronic 
devices and magnetic sensors.8,9 Nanoparticles have an increased 
surface area and therefore have increased   interaction with 
  biological targets. However, the potential for use of   zerovalent 
bismuth nanoparticles in medicine is currently unknown. 
In this work, we present early evidence of the inhibitory 
  antimicrobial effect of bismuth nanoparticles against growth of   
S. mutans and its capability to form a biofilm. The biocidal activ-
ity of bismuth nanoparticles was very similar to that obtained 
with chlorhexidine, a commonly used oral antiseptic.
Materials and methods
Synthesis of zerovalent bismuth 
nanoparticles
The following chemical reagents and methods were used 
for the synthesis of zerovalent bismuth nanoclusters: 
  bismuth nitrate pentahydrate [Bi(NO3)3.5H2O, 98%, Sigma, 
St Louis, MO], sodium citrate dihydrate [Na3(C6H5O7) ⋅ 2H 2O, 
99%, Sigma], sodium borohydride (NaBH4, 99%, Sigma), 
dimethyl sulfoxide (Baker, 99.02%, Avantor, Phillipsburg, NJ), 
methanol (99.8%, Merck, Whitehouse Station, NJ), argon 
(99.99%, Praxair Inc, Biddeford, ME), and 4 Å molecular 
sieves (Linde, Tulsa, OK). All reagents were used as received. 
For a typical preparation of stable colloids, zerovalent 
bismuth nanoparticles were synthesized by reduction of 
bismuth nitrate Bi(NO3)3 ⋅ 5H2O and were then stabilized by 
sodium citrate Na3(C6H5O7) ⋅ 2H 2O. Specifically, 0.0148 g 
of Na3(C6H5O7) ⋅ 2H2O were dissolved in 100 µL of water 
and 24 mL of dimethyl sulfoxide was added. Next, 0.0242 g 
of Bi(NO3)3 ⋅ 5H2O were added to the mixture. The mixture 
was fizzed with argon for 15 minutes, and 1 mL of sodium 
borohydride in methanol 0.2 M NaBH4 was added as reducing 
agent. The final concentrations of each Na3(C6H5O7) ⋅ 2H2O 
and Bi(NO3)3 ⋅ 5H2O were 2 × 10−3 M.
Characterization of zerovalent bismuth 
nanoparticles
The size, distribution, and morphology of the zerovalent 
bismuth nanoparticles were determined by high-resolution 
transmission electron microscopy (TEM) using a JEM 2010 
FasTem microscope equipped with Digital Micrograph 
1.2 software and a high angle annular dark field detector 
as well as energy-dispersive and GIF spectrophotometers, 
at a voltage of 200 kV . Conventional high-resolution TEM 
images were obtained in a Scherzer defocused condition. 
A drop of the colloidal nanoparticles was deposited onto 
200 mesh copper grids coated with a carbon/collodion 
layer. The bismuth rhombohedral phase identification was 
obtained by x-ray diffraction patterns, recorded on a Bruker 
D-8 Advance diffractometer using Cu Kα radiation (20 mA, 
40 kV , λ = 1.5418 Å).
Antimicrobial activity against S. mutans
The antimicrobial effect of the bismuth nanoparticles on 
growth of S. mutans (strain AU130, ATCC 700611,   Manassas, 
VA) was determined using the 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) assay (Biotium, 
Hayward, CA),10,11 following the instructions of the 
  manufacturer. S. mutans was grown in trypticase soy broth 
(BD Difco, Sparks MD) at 37°C overnight in aerobic 
  conditions. The bacteria were counted using a Neubauer 
chamber, and 1 × 104 cells were inoculated in 100 µL of 
trypticase soy broth medium in a 96-well polystyrene plate. 
Three wells with only trypticase soy broth medium were used 
as controls for growth of S. mutans. Chlorhexidine 0.12% 
(Ultradent Products, South Jordan, UT) was used as a positive 
antimicrobial control. We used 2 mM of zerovalent bismuth 
nanoparticles to interfere with bacterial growth. The 96-well 
plate was incubated at 37°C overnight. Next, 10 µL of MTT 
was added to each well, and the plate was protected against 
light and incubated at 37°C for 2 hours. Next, 200 µL of 
dimethyl sulfoxide was added to dissolve the reduced MTT. 
The amount of live cells was determined using a microplate 
absorbance reader (Biorad, Philadelphia, PA) at 595 nm. 
The experiment was repeated three times, and the measured 
optical density was analyzed by descriptive statistics.
Antibiofilm activity
The antibiofilm activity of the bismuth nanoparticles was 
determined by fluorescence microscopy, following the 
methodology described above. To observe the biofilm, 
SYTO 9 green dye (Invitrogen, Carlsbad, CA) was added 
at a final concentration of 20 µM.12,13 The 96-well plate was 
incubated for 30 minutes at room temperature and protected 
against light. The S. mutans biofilm was visualized using a 
Carl Zeiss Z1 Axio Inverter microscope (Thornwood, NY) 
at 485 nm.
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Determination of MIC for zerovalent 
bismuth nanoparticles
The minimal inhibitory concentration (MIC) was   determined 
as previously described.14 Briefly, it was obtained by   dilution 
of a 5 tube in the McFarland scale with 1 × 109 colony-
forming units. S. mutans was grown in trypticase soy broth 
agar and incubated at 37°C for 24 hours. One colony was 
inoculated in 5 mL of trypticase soy broth medium and 
incubated at 37°C for 24 hours. The bacteria count was 
determined with a   Neubauer chamber. Tubes with a final 
concentration of 1 × 106 colony-forming units were obtained 
by dilution of a 5 tube in the McFarland scale. The bismuth 
nanoparticle solution was diluted to final concentrations of 
2, 1.5, 1, 0.5, 0.25, and 0.125 mM. Next, 1 mL of zerovalent 
bismuth nanoparticles was mixed as a bacterial suspension 
and incubated at 37 °C for 18 hours. The MIC was determined 
from the presence or absence of turbidity in the different tubes 
containing the nanoparticles. Chlorhexidine 0.12% was used 
as a positive control for inhibition.
Results
Synthesis of zerovalent bismuth 
nanoparticles
The colloidal dispersions of zerovalent bismuth   nanoparticles 
prepared from 2 × 10−4 M Bi(NO3)3 ⋅ 5H 2O, 4 × 10−4 M 
Na3(C6H5O7) ⋅ 2H 2O, and 4 × 10−4 M NaBH4 in dimethyl 
sulfoxide showed a narrow size distribution and a spherical 
form, with an average size of 3.3 ± 0.97 nm (see Figure 1 
for a typical particle). This mean size is the smallest reported 
in the literature.
Antimicrobial activity against S. mutans
To explore the possible antimicrobial activity of zerovalent 
bismuth nanoparticles, their effect on S. mutans growth 
was determined. The results show that these nanoparticles 
reduced the number of bacteria by 69%, in comparison 
with bacteria grown in medium alone (Figure 2). Similarly, 
treatment with 0.12% chlorhexidine (inhibition control) 
achieved a 63% reduction in the number of bacteria when 
compared with nontreated cells (Figure 2). To rule out any 
antimicrobial effect of dimethyl sulfoxide, it was added 
to the S. mutans cultures and no antimicrobial effect was 
detected after overnight incubation under our experimental 
conditions (data not shown). It is important to emphasize that 
zerovalent bismuth nanoparticles were stable to temperatures 
lower than 50 °C following their characterization. Because all 
experiments were performed at 37 °C, no additional controls 
were used to determine the stability of zerovalent bismuth 
nanoparticles.
Inhibitory effect on biofilm
In the previous experiment, we measured the   antimicrobial 
activity of zerovalent bismuth nanoparticles. In order to 
  analyze for possible biofilm inhibition of S. mutans by bismuth 
nanoclusters, the antibiofilm activity of the   nanoparticles was 
determined by fluorescence   microscopy. The results show 
complete inhibition of biofilm   formation by   chlorhexidine 
(Figure 3B) and zerovalent bismuth   nanoparticles 
 ( Figure 3C), compared with controls   (Figure 3A). The results 
did not change when the   zerovalent bismuth nanoparticles 
were added at different post-inoculation times. We tested 
the inhibitory activity on biofilm at 6 and 18 hours post-
inoculation, and obtained similar results (data not shown). 
Inhibition of S. mutans growing by
Bismuth nanoparticles
Growing control Bismuth nanop Chlorexidine
Antimicrobial agent
S
.
 
m
u
t
a
n
s
 
g
r
o
w
i
n
g
4
3
2
1
0
Figure  2  Antimicrobial  activity  of  zerovalent  bismuth  nanoparticles  against 
Streptococcus mutans growth.
Notes: The y axis shows the optical density units of S. mutans growth. S. mutans 
culture without any inhibitor was used as growing control and chlorhexidine 0.12% 
as a positive inhibition control. Zerovalent bismuth nanoparticles were used at a 
final concentration of 2 mM.
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Figure 1 High-resolution transmission electron microscopic image of an isolated 
zerovalent bismuth nanoparticle. 
Notes: The colloidal sample to obtain this image was prepared a few minutes 
before  the  microscopy  session.  Final  concentrations  of  the  chemical  reagents 
are 2 × 10−3 M Bi(NO3)3 ⋅ 5H2O, 4 × 10−4 M Na3(C6H5O7) ⋅ 2H2O, and 4 × 10−4 M 
NaBH4 in dimethyl sulfoxide.International Journal of Nanomedicine 2012:7
These data indicate that zerovalent bismuth nanoparticles 
had antibiofilm activity which was as effective as that of 
chlorhexidine.
Determination of MIC
In order to characterize the antimicrobial activity of the 
  bismuth nanoclusters, we determined the MIC of the 
  zerovalent bismuth nanoparticles. The result obtained 
was 0.5 mM. This result is important in terms of   knowing 
the   minimal effective quantity of zerovalent bismuth 
  nanoparticles required to inhibit S. mutans growth.
Discussion
Nanotechnology is a new discipline with many applications 
in fields like biological sciences and medicine.   Nanomaterials 
are applied as coating materials, as well as in treatment and 
diagnosis.15 Nanoparticles of titanium, silver, diamond, 
iron oxide, carbon nanotubes, and biodegradable polymers 
have been studied for their use in diagnosis and   treatment. 
Nanoparticles with antimicrobial activity have been 
reported, including ones containing silver, copper oxide, 
and selenium.16–18 The advantages of nanoparticles are their 
high surface-to-volume ratios, their quantum confinement, 
and their nanoscale sizes, which allow more active sites to 
interact with biological systems, including bacteria. This is 
the most important difference between nanoparticles and 
typical antimicrobial agents, and could minimize the risk of 
developing antimicrobial resistance.
The mechanism of antimicrobial activity for nanoparticles 
is not completely understood, and their precise mechanism of 
action against bacteria remains to be fully elucidated. Several 
studies have shown that a positive charge on the metal ion is 
critical for antimicrobial activity, allowing for electrostatic 
attraction between the negative charge on the bacterial cell 
membrane and the positive charge on the nanoparticle.19 
It has been reported that silver nanoparticles can damage 
DNA, alter gene expression, and affect membrane-bound 
respiratory enzymes.20–22
Here we present early evidence of the antimicrobial 
activity of zerovalent bismuth nanoparticles. Their efficacy 
in inhibiting S. mutans growth was comparable with that 
of chlorhexidine. The MIC of zerovalent bismuth nanopar-
ticles for bacterial growth inhibition was 0.5 mM, which 
should be taken into account if they are to be incorporated 
into a mouthwash. Our results indicate that these nanopar-
ticles as antimicrobial agents are as good as chlorhexidine, 
which is the most commonly used oral antiseptic agent. 
Previously it has been reported that silver, copper oxide, 
and selenium nanoparticles have antimicrobial activity.16–18 
In fact, silver nanoparticles have been used to prevent 
biofilm formation on surfaces for both biomedical and 
more general use.23
In order to determine if zerovalent bismuth   nanoparticles 
have the potential to interfere with S. mutans biofilm 
  formation, we studied the antibiofilm activity of these 
  nanoparticles. Surprisingly, they completely prevented 
biofilm formation. This effect was unexpected, given that 
zerovalent bismuth nanoparticles would only reduce cell 
growth and not completely inhibit it. We hypothesize that, 
since 69% of cells were inactivated by these nanoparticles, 
cell survival was not sufficient to form a biofilm. Survival 
bacteria were probably stressed due to the presence of zerova-
lent bismuth nanoparticles and it is possible that they were 
lost during washing out of the excess dye. In the presence 
of chlorhexidine and zerovalent bismuth nanoparticles, we 
only observed cellular debris on a dark background, compris-
ing mainly DNA from dead bacteria with accumulation of 
dye. Morphologically, these dye accumulations differ from 
bacterial biofilm.
In this work, we focused on the effectiveness of   zerovalent 
bismuth nanoparticles in inhibiting growth of S. mutans. 
Overall, the experimental data suggest that these nanopar-
ticles could be an interesting alternative to combat   bacterial 
infections underlying biofilms. The properties of these 
nanoparticles could be used in oral health,   supporting the 
antimicrobial activity of oral antiseptics. Further   experiments 
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Figure 3 Inhibition of Streptococcus mutans biofilm detected by fluorescence microscopy.
Notes: S. mutans culture without any inhibitor was used as growing control and chlorhexidine 0.12% as a positive inhibition control. Zerovalent bismuth nanoparticles were 
used at a final concentration of 2 mM.International Journal of Nanomedicine
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/international-journal-of-nanomedicine-journal
The International Journal of Nanomedicine is an international, peer-
reviewed journal focusing on the application of nanotechnology 
in diagnostics, therapeutics, and drug delivery systems throughout 
the biomedical field. This journal is indexed on PubMed Central, 
MedLine, CAS, SciSearch®, Current Contents®/Clinical Medicine, 
Journal Citation Reports/Science Edition, EMBase, Scopus and the 
Elsevier Bibliographic databases. The manuscript management system 
is completely online and includes a very quick and fair peer-review 
system, which is all easy to use. Visit http://www.dovepress.com/ 
testimonials.php to read real quotes from published authors.
International Journal of Nanomedicine 2012:7
will be necessary to determine the possible toxicity of such 
nanoparticles in human fibroblast culture and to analyze their 
potential use in humans. In conclusion, we report that bismuth 
nanoparticles have antimicrobial activity against growth of 
S. mutans, as well as antibiofilm activity.
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